Tripler Army Medical Center, Honolulu, HI.
Hawaii J Health Soc Welf. 2021 Sep;80(9):207-211.
Papillary fibroelastomas (PFE) are rare primary cardiac tumors characterized by non-malignant, pedunculated, endocardial lesions with a significant risk of embolic potential and death. With improvements in the imaging quality and availability of transthoracic echocardiograms (TTE), the diagnosis of PFE has become more common in the last 2 decades. PFE is changing from a rare "zebra" diagnosis to one that community providers will encounter in their practice and must appropriately treat to prevent morbidity and mortality. Data shows that there are significant survival and morbidity benefit associated with surgical excision over non-operative management, with the benefit of anticoagulation remaining unclear at this time. We report a case describing the diagnostic workup and management of a 58-year-old woman who presented with an unidentified endocardial mass determined to be a PFE. Based on current literature, we favor a strategy of early surgical excision of PFE for an optimal reduction in mortality and thromboembolic sequelae associated with this pathology.
乳头状纤维弹性瘤(PFE)是一种罕见的原发性心脏肿瘤,其特征为良性、带蒂的心内膜病变,具有较大的栓塞潜在风险和死亡风险。随着影像学质量的提高和经胸超声心动图(TTE)的普及,在过去的 20 年中,PFE 的诊断变得更加常见。PFE 正在从一种罕见的“斑马”诊断转变为社区医生在实践中会遇到的诊断,并且必须进行适当的治疗以预防发病率和死亡率。数据表明,与非手术治疗相比,手术切除具有显著的生存和发病率获益,而此时抗凝的获益尚不清楚。我们报告了一例 58 岁女性的病例,该患者因不明原因的心内膜肿块就诊,被确定为 PFE。基于目前的文献,我们赞成对 PFE 进行早期手术切除的策略,以最大限度地降低与该病理相关的死亡率和血栓栓塞后遗症。